Arca
Skip to content
Tools
Tools

Postherpetic neuralgia

Drug research and approvals for postherpetic neuralgia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 15 studies of postherpetic neuralgia are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 4 approved and 12 open orphan designations naming it.

  • Recruiting worldwide: 15
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 4
  • EU medicines: 0

Recruiting now

Newest posted first, of 15 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 3

Phase 3 5

Phase 2 12 of 26

Phase 1 or earlier 3

How its trials ended

168 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 55 whose ending is known, 55% met their primary endpoint, 7% missed it and 38% stopped early.

  • Completed, result not reported8048%
  • Met its primary endpoint3018%
  • Stopped: other or unclear1710%
  • Status unknown1710%
  • Ongoing1610%
  • Missed its primary endpoint42%
  • Stopped: enrollment or feasibility32%
  • Stopped: sponsor or business decision11%

FDA orphan designations

Approved first, then open designations, newest first; 15 of 16
Jun 6, 2012HorizantManagement of postherpetic neuralgia in adults.Arbor Pharmaceuticals, LLCApproved
Jan 28, 2011GraliseFor the management of postherpetic neuralgiaGolf Acquiror LLCApproved
Nov 16, 2009QutenzaManagement of neuropathic pain associated with postherpetic neuralgiaAveritas Pharma, Inc.Approved
Mar 19, 1999Lidoderm PatchFor relief of allodynia (painful hypersensitivity), and chronic pain in postherpetic neuralgia.Teikoku Pharma USA, Inc.Approved
Jun 2, 2016D-methadoneTreatment of postherpetic neuralgiaLevomecor Inc.Designated
May 31, 2016Bupivacaine hydrochlorideTreatment of pain associated with postherpetic neuralgia.Grace Therapeutics, Inc.Designated
Feb 23, 2015NaltrexoneTreatment of postherpetic neuralgiaAllodynic Therapeutics LLCDesignated
Apr 14, 2014naltrexone/clonidine combinationTreatment of postherpetic neuralgiaAllodynic Therapeutics LLCDesignated
Jan 19, 2010Amitriptyline and ketamineTreatment of postherpetic neuralgiaImmune Pharmaceuicals, Inc.Designated
Feb 17, 2009CivamideTreatment of postherpetic neuralgia.Winston Laboratories, Inc.Designated
Jun 18, 2008BupivacaineRelief of persistent pain associated with postherpetic neuralgiaDURECT CorporationDesignated
Jan 8, 2007MepivacaineTreatment of postherpetic neuralgiaRelmada Therapeutics, Inc.Designated
Aug 3, 2005CapsaicinTreatment of postherpetic neuralgia.TheraQuest Biosciences, LLCDesignated
Jul 8, 2005AlfentanilManagement of postherpetic neuralgiaCinergen, LLCDesignated
Apr 26, 2005Tramadol hydrochlorideManagement of postherpetic neuralgiaTheraQuest Biosciences, LLCDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.